Active Ingredient: Each film-coated tablet contains 140.45 mg sildenafil citrate, equivalent to 100 mg sildenafil.

Excipients: Microcrystalline cellulose, calcium hydrogen phosphate (anhydrous), croscarmellose sodium, magnesium stearate, indigo carmine (E132), hydroxypropyl methylcellulose, lactose monohydrate (obtained from bovine milk), titanium dioxide (E171), triacetin, yellow iron oxide (E172).

Before you start using this medicine, read this INSTRUCTIONS FOR USE carefully, because it contains important information for you.

Detailed information for this product is available in the patient information leaflet.

Instructions for proper use and dosage/frequency of administration

DEGRA should not be used in those under 18 years of age.

No special dosage adjustment is required for elderly patients.

A sildenafil dose of 25 mg is recommended in patients with severe renal impairment.

A sildenafil dose of 25 mg is recommended in patients with liver impairment (for example, a chronic liver disease such as cirrhosis).

Like all medicines, side effects may occur in people sensitive to the substances contained in DEGRA. Side effects were generally temporary or moderate in severity. The following side effects have been reported at recommended doses.

Side effects are classified as shown in the following categories:

If any of the following occur, stop using DEGRA and immediately go to the emergency department of your nearest hospital:

Other side effects are as follows

Unstable angina (a heart-related disease) and sudden death have been reported in post-marketing experience.